Targeting serine proteases in asthma

Current Topics in Medicinal Chemistry

Volumn 6, Issue 4, 2006, Pages 393-402

  Guay, Caroline ^a   Laviolette, Michel ^a   Tremblay, Guy M ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Asthma; Chymase; Inflammation; Leukocyte elastase; Serine protease inhibitors; Tryptase

Indexed keywords

2 (5 FORMYLAMINO 6 OXO 2 PHENYL 1,6 DIHYDROPYRIMIDINE 1 YL) N [3,4 DIOXO 1 PHENYL 7 (2PYRIDYLOXY) 2 HEPTYL]ACETAMIDE; 2 [4 (5 FLUORO 3 METHYLBENZO[B]THIOPHENE 2 YL)SULFONAMIDO 3 METHANESULFONYLPHENYL]OXAZOLE 4 CARBOXYLIC ACID; 2 [5 AMINO 2 (4 FLUOROPHENYL) 1,6 DIHYDRO 6 OXO 1 PYRIMIDINYL] N [1 [(5 METHOXYCARBONYL 2 BENZOXAZOLYL)CARBONYL] 2 PHENYLETHYL]ACETAMIDE; 3 [(3 AMINO 4 CARBOXY)PHENYLSULFONYL] 7 CHLOROQUINAZOLINE 2,4(1H,3H) DIONE; 4 [1 (NAPHTHYLMETHYL)BENZIMIDAZOL 2 YLTHIO]BUTANOIC ACID; ALPHA 1 ANTITRYPSIN; APC 2059; AVE 8923; BETA KETOPHOSPHONATE 1; BETA RIBOFURANOSYLBRUNFELSAMIDINE; BMS 262084; BMS 363130; BMS 363131; CATHEPSIN G; CHYMASE INHIBITOR; DEPELESTAT; DX 890; ELASTASE; GRANZYME B; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; LEUKOCYTE ELASTASE INHIBITOR; MYELOBLASTIN; N (1 HYDROXY 2 NAPHTHOYL)ARGINYLPROLINAMIDE; N [1 BENZYL 2,3 DIOXO 6 (2 PYRIDYLOXY)HEXYL] 2 (5 FORMYLAMINO 1,6 DIHYDRO 6 OXO 2 PHENYL 1 PYRIMIDINYL)ACETAMIDE; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; SIVELESTAT; SUN C8257; TEI E 548; TRANSFORMING GROWTH FACTOR; TRYPTASE INHIBITOR; TY 51076; TY 51184; UNCLASSIFIED DRUG; UNINDEXED DRUG; ZEMAIRA;

ASTHMA; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; CYTOTOXIC T LYMPHOCYTE; DERMATITIS; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG HALF LIFE; DRUG MECHANISM; DRUG STRUCTURE; DRUG TARGETING; ENZYME INHIBITION; GENE TARGETING; HUMAN; LEUKOCYTE; LUNG ALVEOLUS CELL; MAST CELL; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; REVIEW; STRUCTURE ANALYSIS;

ANIMALS; ASTHMA; HUMANS; SERINE PROTEINASE INHIBITORS;

EID: 33646155563     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802606776287054     Document Type: Review

References (156)

1. Leonard, P.; Sur, S. Asthma: Future Directions. Med Clin. North Am. 2002, 86, 1131-1156.
2. Ferreira, M. A. R. Inflammation in Allergic Asthma: Initiating Events, Immunological Response and Risk Factors. Respirology 2004, 9, 16-24.
3. Larché, M.; Robinson, D. S.; Kay, A. B. The Role of T Lymphocytes in the Pathogenesis of Asthma. J. Allergy Clin. Immunol. 2003, 111, 450-463.
4. Brightling, C. E.; Bradding, P. The Re-Emergence of the Mast Cell as a Pivotal Cell in Asthma Pathogenesis. Curr. Allergy Asthma Rep. 2005, 5, 130-135.
5. Kay, A. B. The Role of Eosinophils in the Pathogenesis of Asthma. Trends Mol. Med. 2005, 11, 148-152.
6. Ennis, M. Neutrophils in Asthma Pathophysiology. Curr. Allergy Asthma Rep. 2003, 3, 159-165.
7. McElvaney, N.G.; Crystal, R.G. Proteases and Lung Injury. In The Lung: Scientific Foundations. 2 ed; Crystal, R. G.; West, J. B.; Weibel, E. R.; Barnes, P. J.; Eds.; Lippincott-Raven Publishers: Philadelphia, 1997; pp 2205-2218.
8. MeElvaney, N.G.; Crystal, R.G. Antiproteases and Lung Defense. In The Lung: Scientific Foundations. 2 ed; Crystal, R. G.; West, J. B.; Weibel, E. R.; Barnes, P. J.; Eds.; Lippincott-Raven Publishers: Philadelphia, 1997; pp 2219-2235.
9. 1-Antitrypsin in Sputum of Asthmatic Patients. Am. J. Respir. Crit. Care Med. 1998, 157, 505-511.
10. Simpson, J. L.; Scott, R. J.; Boyle, M. J.; Gibson, P. G. Differential Proteolytic Enzyme Activity in Eosinophilic and Neutrophilic Asthma. Am. J. Respir. Crit. Care Med. 2005, 172, 559-565.
11. + Lymphocytes and Soluble Granzyme B in Bronchoalveolar Lavage of Allergen Challenged Patients With Atopic Asthma. Clin. Exp. Immunol. 2004, 136, 542-548.
12. Wu, J.; Kobayashi, M.; Sousa, E. A.; Liu, W.; Cai, J.; Goldman, S. J.; Dorner, A. J.; Projan, S. J.; Kavuru, M. S.; Qiu, Y.; Thomassen, M. J. Differential Proteomic Analysis of Bronchoalveolar Lavage Fluid in Asthmatics Following Segmental Antigen Challenge. Mol. Cell. Proteomics 2005, 4, 1251-1264.
13. Hallstrand, T. S.; Moody, M. W.; Wurfel, M. M.; Schwartz, L. B.; Henderson, W. R. Jr.; Aitken, M. L. Inflammatory Basis of Exercise-Induced Bronchoconstriction. Am. J. Respir. Crit. Care Med. 2005, 172, 679-686.
14. Iwanaga, T.; McEuen, A.; Walls, A. F.; Clough, J. B.; Keith, T. P.; Rorke, S.; Barton, S. J.; Holgate, S. T.; Holloway, J. W. Polymorphism of the Mast Cell Chymase Gene (CMA1) Promoter Region: Lack of Association With Asthma but Association With Serum Total Imnumoglobulin E Levels in Adult Atopic Dermatitis. Clin. Exp. Allergy 2004, 34, 1037-1042.
15. Weidinger, S.; Rümmler, L.; Klopp, N.; Wagenpfeil, S.; Baurecht, H. J.; Fischer, G.; Holle, R.; Gauger, A.; Schäfer, T.; Jakob, T.; Ollert, M.; Behrendt, H.; Wichmann, H. E.; Ring, J.; Illig, T. Association Study of Mast Cell Chymase Polymorphisms With Atopy. Allergy 2005, 60, 1256-1261.
16. Woodruff, P. G., Dolganov, G. M., Dao-Pick, T. P., Barker, C. S., Yang, J. H., Lazarus, S. C., Boushey, H. A., Erle, D. J., and Fahy, J. V. Genome Wide Profiling in Airway Epithelial Cells From Asthmatics and Smokers [Abstract]. Proc. Am. Thorac. Soc. 2005, 2, A729.
17. Malerba, G.; Pignatti, P. F. A Review of Asthma Genetics: Gene Expression Studies and Recent Candidates. J. Appl. Genet. 2005, 46, 93-104.
18. m Repeat Polymorphism 254 bp Downstream of the Mast Cell Chymase (CMAI) Gene Is Associated With Atopic Asthma and Total Serum IgE Levels. J. Hum. Genet. 2005, 50, 276-282
19. Kauffman, H. F. Interaction of Environmental Allergens With Airway Epithelium as a Key Component of Asthma. Curr. Allergy Asthma Rep. 2003, 3, 101-108.
20. Demedts, I. K.; Brusselle, G. G.; Bracke, K. R.; Vermaelen, K. Y.; Pauwels, R. A. Matrix Metalloproteinases in Asthma and COPD. Curr. Opin. Pharmacol. 2005, 5, 257-263.
21. Schwartz, L. B.; Lewis, R. A.; Austen, K. F. Tryptase From Human Pulmonary Mast Cells: Purification and Characterization. J. Biol. Chem. 1981, 256, 11939-11943.
22. Sommerhoff, C. P.; Bode, W.; Matschiner, G.; Bergner, A.; Fritz, H. The Human Mast Cell Tryptase Tetramer: A Fascinating Riddle Solved by Structure. Biochim. Biophys. Acta 2000, 1477, 75-89.
23. Rawlings, N. D.; Tolle, D. P.; Barrett, A. J. MEROPS: The Peptidase Database. Nucleic Acids Res. 2004, D160-DI64.
24. Fiorucci, L.; Ascoli, F. Mast Cell Tryptase, a Still Enigmatic Enzyme. Cell. Mol. Life Sci. 2004, 61, 1278-1295.
25. Caughey, G. H.; Raymond, W. W.; Blount, J. L.; Hau, L. W.-T.; Pallaoro, M.; Wolters, P. J.; Verghese, G. M. Characterization of Human γ-Tryptases, Novel Members of the Chromosome 16p Mast Cell Tryptase and Prostasin Gene Families. J. Immunol. 2000, 164, 6566-6575.
26. Sommerhoff, C. P. Mast Cell Tryptases and Airway Remodeling. Am. J. Respir. Crit. Care Med. 2001, 164, s52-s58.
27. Wang, H.-W.; McNeil, H. P.; Husain, A.; Liu, K.; Tedla, N.; Thomas, P. S.; Raftery, M.; King, G. C.; Cai, Z. Y.; Hunt, J. E. δ Tryptase Is Expressed in Multiple Human Tissues, and a Recombinant Form Has Proteolytic Activity. J. Immunol. 2002, 169, 5145-5152.
28. Wong, G. W.; Yasuda, S.; Madhusudhan, M. S.; Li, L.; Yang, Y.; Krilis, S. A.; Sali, A.; Stevens, R. L. Human Tryptase ε (PRSS22), a New Member of the Chromosome 16pl3.3 Family of Human Serine Proteases Expressed in Airway Epithelial Cells. J. Biol. Chem. 2001, 276, 49169-49182.
29. Oettgen, H. C.; Geha, R. S. IgE Regulation and Roles in Asthma Pathogenesis. J. Allergy Clin. Imumunol. 2001, 107, 429-440.
30. Yamasaki, S.; Saito, T. Regulation of Mast Cell Activation Through FcεRI. Chem. Immunol. Allergy 2005, 87, 22-31.
31. Temkin, V.; Kantor, B.; Weg, V.; Hartman, M.-L.; Levi-Schaffer, F. Tryptase Activates the Mitogen-Activated Protein Kinase/Activator Protein-1 Pathway in Human Peripheral Blood Eosinophils, Causing Cytokine Production and Release. J. Immunol. 2002, 169, 2662-2669.
32. Takizawa, T.; Tamiya, M.; Hara, T.; Matsumoto, J.; Saito, N.; Kanke, T.; Kawagoe, J.; Hattori, Y. Abrogation of Bronchial Eosinophilic Inflammation and Attenuated Eotaxin Content in Protease-Activated Receptor 2-Deficient Mice. J. Pharmacol. Sci. 2005, 98, 99-102.
33. Vliagoftis, H.; Lacy, P.; Luy, B.; Adamko, D.; Hollenberg, M.; Befus, D.; Moqbel, R. Mast Cell Tryptase Activates Peripheral Blood Eosinophils to Release Granule-Associated Enzymes. Int. Arch. Allergy Immunol. 2004, 135, 196-204.
34. He, S.; Peng, Q.; Walls, A. F. Potent Induction of a Neutrophil and Eosinophil-Rich Infiltrate in Vivo by Human Mast Cell Tryptase: Selective Enhancement of Eosinophil Recruitment by Histamine. J. Immunol. 1997, 159, 6216-6225
35. Berger, P.; Girodet, P.-O.; Begueret, H.; Ousova, O.; Perng, D.-W.; Marthan, R.; Walls, A. F.; Tunon de Lara, J. M. Tryptase-Stimulated Human Airway Smooth Muscle Cells Induce Cytokine Synthesis and Mast Cell Chemotaxis. FASEB J. 2003, 17, 2139-2141.
36. He, S.-H.; Chen, P.; Chen, H.-Q. Modulation of Enzymatic Activity of Human Mast Cell Tryptase and Chymase by Protease Inhibitors. Acta Pharmacol. Sin. 2003, 24, 923-929.
37. Sekizawa, K.; Caughey, G. H.; Lazarus, S. C.; Gold, W. M.; Nadel, J. A. Mast Cell Tryptase Causes Airway Smooth Muscle Hyperresponsiveness in Dogs. J. Clin. Invest. 1989, 83, 175-179.
38. Molinari, J. F.; Scuri, M.; Moore, W. R.; Clark, J.; Tanaka, R.; Abraham, W. M. Inhaled Tryptase Causes Bronchoconstriction in Sheep Via Histamine Release. Am. J. Respir. Crit. Care Med 1996, 154, 649-653
39. Johnson, P. R. A.; Ammit, A. J.; Carlin, S. M.; Armour, C. L.; Caughey, G. H.; Black, J. L. Mast Cell Tryptase Potentiates Histamine-Induced Contraction in Human Sensitized Bronchus. Eur. Respir. J. 1997, 10, 38-43.
40. Barrios, V. E.; Middelton, S. C.; Kashem, M. A.; Havill, A. M.; Toombs, C. F.; Wright, C. D. Tryptase Mediates Hyperresponsiveness in Isolated Guinea Pig Bronchi. Life Sci. 1998, 63, 2295-2303.
41. Berger, P.; Compton, S. J.; Molimard, M.; Walls, A. F.; N'Guyen, C.; Marthan, R.; Tunon-de-Lara, J. M. Mast Cell Tryptase as a Mediator of Hyperresponsiveness in Human Isolated Bronchi. Clin. Exp. Allergy 1989, 29, 804-812.
42. Tam, E. K.; Caughey, G. H. Degradation of Airway Neuropeptides by Human Lung Tryptase. Am. J. Respir. Cell Mol. Biol. 1990, 3, 27-32.
43. Berger, P.; Perng, D.-W.; Thabrew, H.; Compton, S. J.; Cairns, J. A.; McEuen, A. R.; Marthan, R.; Tunon De Lara, J.-M.; Walls, A. F. Tryptase and Agonists of PAR-2 Induce the Proliferation of Human Airway Smooth Muscle Cells. J. Appl. Physiol. 2001, 91, 1372-1379.
44. Trian, T.; Girodet, P.-O.; Ousova, O.; Marthan, R.; Tunon-de-Lara, J. M.; Berger, P. RNA Interference Decreases PAR-2 Expression and Function in Human Airway Smooth Muscle Cells. Am. J. Respir. Cell Mol. Biol. 2006, 34, 49-55.
45. Brown, J. K.; Hollenberg, M. D.; Jones, C. A. Tryptase Activates Phosphatidylinositol 3-Kinases Proteolytically Independently From Proteinase-Activated Receptor-2 in Cultured Dog Airway Smooth Muscle Cells. Am. J. Physiol. 2006, 290, L259-L269.
46. Saito, H. Role of Mast Cell Proteases in Tissue Remodeling. Chem. Immunol. Allergy 2005, 87, 80-84.
47. Berger, P.; Girodet, P.-O.; Manuel Tunon-de-Lara, J. Mast Cell Myositis: a New Feature of Allergic Asthma? Allergy 2005, 60, 1238-1240.
48. Bachelet, I.; Munitz, A.; Levi-Schaffer, F. Co-Culture of Mast Cells With Fibroblasts: A Tool to Study Their Crosstalk. Methods Mol. Biol. 2006, 315, 295-317
49. Akers, I. A.; Parsons, M.; Hill, M. R.; Hollenberg, M. D.; Sanjar, S.; Laurent, G. J.; McAnulty, R. J. Mast Cell Tryptase Stimulates Human Lung Fibroblast Proliferation Via Protease-Activated Receptor-2. Am. J. Physiol. 2000, 278, L193-L201.
50. Garbuzenko, E.; Nagler, A.; Pickholtz, D.; Gillery, P.; Reich, R.; Maquart, F.-X.; Levi-Schaffer, F. Human Mast Cells Stimulate Fibroblast Proliferation, Collagen Synthesis and Lattice Contraction: A Direct Role for Mast Cells in Skin Fibrosis. Clin. Exp. Allergy 2002, 32, 237-2464
51. Albrecht, M.; Frungieri, M. B.; Kunz, L.; Rämsch, R.; Meineke, V.; Köhn, F. M.; Mayerhofer, A. Divergent Effects of the Major Mast Cell Products Histamine, Tryptase and TNF-Alpha on Human Fibroblast Behaviour. Cell. Mol. Life Sci. 2005, 62, 2867-2876.
52. Asano-Kato, N.; Fukagawa, K.; Okada, N.; Dogru, M.; Tsubota, K.; Fujishima, H. Tryptase Increases Proliferative Activity of Human Conjunctival Fibroblasts Through Protease-Activated Receptor-2. Invest. Ophthalmol. Vis. Sci. 2005, 46, 4622-4626.
53. Cairns, J. A.; Walls, A. F. Mast Cell Tryptase Stimulates the Synthesis of Type I Collagen in Human Lung Fibroblasts. J. Clin. Invest. 1997, 99, 1313-1321.
54. Frungieri, M. B.; Albrecht, M.; Raemsch, R.; Mayerhofer, A. The Action of the Mast Cell Product Tryptase on Cyclooxygenase-2 (COX2) and Subsequent Fibroblast Proliferation Involves Activation of the Extracellular Signal-Regulated Kinase Isoforms I and 2 (erk1/2). Cell. Signal. 2005, 17, 525-533
55. Holgate, S. T.; Lackie, P. M.; Davies, D. E.; Roche, W. R.; Walls, A. F. The Bronchial Epithelium As a Key Regulator of Airway Inflammation and Remodelling in Asthma. Clin. Exp. Allergy 1999, 29 Suppl 2, 90-95,
56. Cairns, J. A. Inhibitors of Mast Cell Tryptase Beta As Therapeutics for the Treatment of Asthma and Inflammatory Disorders. Pulm. Pharmacol. Ther. 2005, 18, 55-66.
57. Krishna, M. T.; Chauhan, A.; Little, L.; Sampson, K.; Hawksworth, R.; Mant, T.; Djukanovic, R.; Lee, T.; Holgate, S. Inhibition of Mast Cell Tryptase by Inhaled APC 366 Attenuates Allergen-Induced Late-Phase Airway Obstruction in Asthma. J. Allergy Clin. Immunol. 2001, 107, 1039-1045.
58. Calkins, K. Celera Not Inhibited by Triptases. BioCentury, The Bernstein Report on BioBusiness 2005, 10, A12.
59. Hopkins, C.; Neuenschwander, K.; Scotese, A.; Jackson, S.; Nieduzak, T.; Pauls, H.; Liang, G.; Sides, K.; Cramer, D.; Cairns, J.; Maignan, S.; Mathieu, M. Novel Pyrazinone Inhibitors of Mast Cell Tryptase: Synthesis and SAR Evaluation. Bioorg. Med. Chem. Lett. 2004, 14, 4819-4823.
60. Vaz, R. J.; Gao, Z.; Pribish, J.; Chen, X.; Levell, J.; Davis, L.; Albert, E.; Brollo, M.; Ugolini, A.; Cramer, D. M.; Cairns, J.; Sides, K.; Liu, F.; Kwong, J.; Kang, J.; Rebello, S.; Elliot, M.; Lim, H.; Chellaraj, V.; Singleton, R. W.; Li, Y. Design of Bivalent Ligands Using Hydrogen Bond Linkers: Synthesis and Evaluation of Inhibitors for Human β-Tryptase. Bioorg. Med. Chem. Lett. 2004, 14, 6053-6056.
61. Levell, J.; Astles, P.; Eastwood, P.; Cairns, J.; Houille, O.; Aldous, S.; Merriman, G.; Whiteley, B.; Pribish, J.; Czekaj, M.; Liang, G.; Maignan, S.; Guilloteau, J.-P.; Dupuy, A.; Davidson, J.; Harrison, T.; Morley, A.; Watson, S.; Fenton, G.; McCarthy, C.; Romano, J.; Mathew, R.; Engers, D.; Gardyan, M.; Sides, K.; Kwong, J.; Tsay, J.; Rebello, S.; Shen, L.; Wang, J.; Luo, Y.; Giardino, O.; Lim, H.-K.; Smith, K.; Pauls, H. Structure Based Design of 4-(3-Aminomethylphenyl) Piperidinyl-1-Amides: Novel, Potent, Selective, and Orally Bioavailable Inhibitors of βII Tryptase. Bioorg. Med. Chem. 2005, 13, 2859-2872.
62. Hopkins, C. R.; Czekaj, M.; Kaye, S. S.; Gao, Z.; Pribish, J.; Pauls, H.; Liang, G.; Sides, K.; Cramer, D.; Cairns, J.; Luo, Y.; Lim, H.-K.; Vaz, R.; Rebello, S.; Maignan, S.; Dupuy, A.; Mathieu, M.; Levell, J. Design, Synthesis, and Biological Activity of Potent and Selective Inhibitors of Mast Cell Tryptase. Bioorg. Med. Chem. Lett. 2005, 15, 2734-2737.
63. Qian, X.; Zheng, B.; Burke, B.; Saindane, M. T.; Kronenthal, D. R. A Stereoselective Synthesis of BMS-262084, an Azetidinone-Based Tryptase Inhibitor. J. Org. Chem. 2002, 67, 3595-3600.
64. Slusarchyk, W. A.; Bolton S. A.; Hartl, K. S.; Huang, M. H.; Jacobs, G.; Meng, W.; Ogletree, M. L.; Pi, Z.; Schumacher, W. A.; Seiler, S. M.; Sutton, J. C.; Treuner, U.; Zahler, R.; Zhao, G.; Bisacchi, G. S. Synthesis of Potent and Highly Selective Inhibitors of Human Tryptase. Bioorg. Med. Chem. Lett. 2002, 12, 3235-3238.
65. Bisacchi, G. S.; Slusarchyk, W. A.; Bolton, S. A.; Hartl, K. S.; Jacobs, G.; Mathur, A.; Meng, W.; Ogletree, M. L.; Pi, Z.; Sutton, J. C.; Treuner, U.; Zahler, R.; Zhao, G.; Seiler, S. M. Synthesis of Potent and Highly Selective Nonguanidine Azetidimone Inhibitors of Human Tryptase. Bioorg. Med. Chem. Lett. 2004, 14, 2227-2231.
66. Zhao, G.; Bolton, S. A.; Kwon, C.; Hartl, K. S.; Seiler, S. M.; Slusarchyk, W. A.; Sutton, J. C.; Bisacchi, G. S. Synthesis of Potent and Selective 2-Azepanone Inhibitors of Human Tryptase. Bioorg. Med. Chem. Lett. 2004, 14, 309-312.
67. Kamath, A. V.; Morrison, R. A.; Harper, T. W.; Lan, S.-J.; Marino, A. M.; Chong, S. Multiple Pathways Are Involved in the Oral Absorption of BMS-262084, a Tryptase Inhibitor, in Rats: Role of Paracellular Transport, Binding to Trypsin, and P-Glycoprotein Efflux. J. Pharm. Sci. 2005, 94, 1115-1123.
68. Scarpi, D.; McBride, J. D.; Leatherbarrow, R. J. Inhibition of Human β-Tryptase by Bowman-Birk Inhibitor Derived Peptides. J. Pept. Res. 2002, 59, 90-93.
69. Scarpi, D.; McBride, J. D.; Leatherbarrow, R. J. Inhibition of Human β-Tryptase by Bowman-Birk Inhibitor Derived Peptides: Creation of a New Tri-Functional Inhibitor. Bioorg. Med. Chem. 2004, 12, 6045-6052.
70. Jaulent, A. M.; Leatherbarrow, R. J. Design, Synthesis and Analysis of Novel Bicyclic and Bifunctional Protease Inhibitors. Protein Eng. Des. Sel. 2004, 17, 681-687.
71. del Fresno, M.; Fernández-Forner, D.; Miralpeix, M.; Segarra, V.; Ryder, H.; Royo, M.; Albericio, F. Combinatorial Approaches Towards the Discovery of New Tryptase Inhibitors. Bioorg. Med. Chem. Lett. 2005, 15, 1659-1664.
72. Wong, T.; Groutas, C. S.; Mohan, S.; Lai, Z.; Alliston, K. R.; Vu, N.; Schechter, N. M.; Groutas, W. C. 1,2,5-Thiadiazolidin-3-One 1,1-Dioxide-Based Heterocyclic Sulfides Are Potent Inhibitors of Human Tryptase. Arch. Biochem. Biophys. 2005, 436, 1-7.
73. Scheerens, H., Tan, S., Sweeney, T. D., Perera, T. V., Baruch, A., Beltman, J., Graupe, D., Liu, L., Tai, V., Lee, S., Mendonca, R., Sperandio, D.; Dalrymple, S. A. A Selective Small Molecule Inhibitor of Tryptase Blocks Airway Hyperresponsiveness and Inflammation in a Mouse Model of Allergic Asthma [Abstract]. Proc. Am. Thorac. Soc. 2005, 2, A804.
74. Elrod, K. C.; Moore, W. R.; Abraham, W. M.; Tanaka, R. D. Lactoferrin, a Potent Tryptase Inhibitor, Abolishes Late-Phase Airway Responses in Allergic Sheep. Am. J. Respir. Crit. Care Med. 1997, 156, 375-381.
75. Hallgren, J.; Estrada, S.; Karlson, U.; Alving, K.; Pejler, G. Heparin Antagonists Are Potent Inhibitors of Mast Cell Tryptase. Biochemistry 2001, 40, 7342-7349.
76. Lundequist, A.; Juliano, M. A.; Juliano, L.; Pejler, G. Polycationic Peptides As Inhibitors of Mast Cell Serine Proteases. Biochem. Pharmacol. 2003, 65, 1171-1180.
77. Sommerhoff, C. P.; Söllner, C.; Mentele, R.; Piechottka, G. P.; Auerswald, E. A.; Fritz, H. A Kazal-Type Inhibitor of Human Mast Cell Tryptase: Isolation From the Medical Leech Hirudo medicinalis, Characterization, and Sequence Analysis. Biol. Chem. Hoppe Seyler 1994, 375, 685-694.
78. Murakami, Y.; Takei, M.; Shindo, K.; Kitazume, C.; Tanaka, J.; Higa, T.; Fukamachi, H. Cyclotheonamide E4 and E5, New Potent Tryptase Inhibitors From an Ircinia Species of Sponge. J. Nat. Prod. 2002, 65, 259-261.
79. Yang, L. K.; Ng, S. P.; Flotow, H.; Yoganathan, K.; Daramola, B. O.; Soejarto, D. D.; Buss, A. D.; Butler, M. S. Pyrrole Carboxamidine Tryptase Inhibitors From Leptonychia pubescens. Planta Med. 2005, 71, 1071-1072.
80. Caughey, G.H. Chymases. In Handbook of Proteolytic Enzymes. 2nd ed; Barrett, A. J.; Rawlings, N. D.; Woessner, J. F.; Eds.; Academic Press: New York, 2004 pp 1531-1535.
81. He, S.; Walls, A. F. The Induction of a Prolonged Increase in Microvascular Permeability by Human Mast Cell Chymase. Eur. J. Pharmacol. 1998, 352, 91-98.
82. Mizutani, H.; Schechter, N.; Lazarus, G.; Black, R. A.; Kupper, T. S. Rapid and Specific Conversion of Precursor Interleukin 1β (IL-1β) to an Active IL-1 Species by Human Mast Cell Chymase. J. Exp. Med. 1991, 174, 821-825.
83. Longley, B. J.; Tyrrell, L.; Ma, Y.; Williams, D. A.; Halaban, R.; Langley, K.; Lu, H. S.; Schechter, N. M. Chymase Cleavage of Stem Cell Factor Yields a Bioactive, Soluble Product Proc. Natl. Acad. Sci. U. S. A. 1997, 94, 9017-9021.
84. He, S.; Walls, A. F. Human Mast Cell Chymase Induces the Accumulation of Neutrophils, Eosinophils and Other Inflammatory Cells in Vivo. Br. J. Pharmacol. I998, 125, 1491-1500.
85. Tani, K.; Ogushi, F.; Kido, H.; Kawano, T.; Kunori, Y.; Kamimura, T.; Cui, P.; Sone, S. Chymase Is a Potent Chemoattractant for Human Monocytes and Neutrophils. J. Leukoc. Biol. 2000, 67, 585-589.
86. Lindberg, B. F.; Gyllstedt, E.; Andersson, K.-E. Conversion of Angiotensin I to Angiotensin II by Chymase Activity in Human Pulmonary Membranes. Peptides 1997, 18, 847-853.
87. Suzuki, Y.; Ruiz-Ortega, M.; Lorenzo, O.; Ruperez, M.; Esteban, V.; Egido, J. Inflammation and Angiotensin II. Int. J. Biochem. Cell Biol. 2003, 35, 881-900.
88. Gosens, R.; Schaafsma, D.; Grootte Bromhaar, M. M.; Vrugt B.; Zaagsma, J.; Meurs, H.; Nelemans, S. A. Growth Factor-Induced Contraction of Human Bronchial Smooth Muscle Is Rho-Kinase-Dependent. Eur. J. Pharmacol. 2004, 494, 73-76.
89. Marshall, R. P.; McAnulty, R. J.; Laurent, G. J. Angiotensin II Is Mitogenic for Human Lung Fibroblasts Via Activation of the Type 1 Receptor. Am. J. Respir, Crit. Care Med. 2000, 161, 1999-2004.
90. 84 Bond by Mast Cell Chymase. J. Biol. Chem. 1994, 269, 18134-18140.
91. Kofford, M. W.; Schwartz, L. B.; Schechter, N. M.; Yager, D. R.; Diegelmann, R. F.; Graham, M. F. Cleavage of Type 1 Procollagen by Human Mast Cell Chymase Initiates Collagen Fibril Formation and Generates a Unique Carboxyl-Terminal Propeptide. J. Biol. Chem. 1997, 272, 7127-7131.
92. He, S. and Zheng, J. Stimulation of Mucin Secretion From Human Bronchial Epithelial Cells by Mast Cell Chymase. Acta Pharmacol. Sin. 2004, 25, 827-832.
93. Gordins, P., Purkiss, J. R., Lackie, P. M., Adam, E. C., McEuen, A. R., and Walls, A. F. The Inhibition of Epithelial Repair by Mast Cell Chymase [Abstract]. J. Allergy Clin. Immunol. 2005, 115, S206.
94. Fahy, J. V. Remodeling of the Airway Epithelium in Asthma. Am. J. Respir. Crit. Care Med. 2001, 164, S46-S51.
95. Yoshikawa,. T.; Imada, T.; Nakakubo, H.; Nakamura, N.; Naito, K. Rat Mast Cell Protease-I Enhances Immunoglobulin E Production by Mouse B Cells Stimulated With Interleukin-4. Immunology 2001, 104, 333-340.
96. Imada, T.; Komorita, N.; Kobayashi, F.; Naito, K.; Yoshikawa, T.; Miyazaki, M.; Nakamura, N.; Kondo, T. Therapeutic Potential of a Specific Chymase Inhibitor in Atopic Dermatitis. Jpn. J. Pharmacol. 2002, 90, 214-217.
97. Akahoshi, F. Nonpeptidic Chymase Inhibitors: Design and Structure-Activity Relationships of Pyrimidinone Derivatives Based on the Predicted Binding Mode of a Peptidic Inhibitor. Curr. Pharm. Des. 2003, 9, 1191-1199.
98. Muto, T.; Fukami, H. Recent Chymase Inhibitors and Their Effects in in vtvo Models. IDrugs 2002, 5, 1141-1150.
99. Koide, Y.; Tatsui, A.; Hasegawa, T.; Murakami, A.; Satoh, S.; Yamada, H.; Kazayama, S.; Takahashi, A. Identification of a Stable Chymase Inhibitor Using a Pharmacophore-Based Database Search. Bioorg. Med. Chem. Lett. 2003, 13, 25-29.
100. Masaki, H.; Mizuno, Y.; Tatui, A.; Murakami, A.; Koide, Y.; Satoh, S.; Takahashi, A. Structure-Activity Relationship of Benzo[b]Thiophene-2-Sulfonamide Derivatives As Novel Human Chymase Inhibitors. Bioorg, Med. Chem. Lett. 2003, 13, 4085-4088.
101. Takai, S.; Jin, D.; Sakaguchi, M.; Miyazaki, M. A Single Treatment With a Specific Chymase Inhibitor, TY-51184, Prevents Vascular Proliferation in Canine Grafted Veins. J. Pharmacol. Sci. 2004, 94, 443-448.
102. Okamoto, Y.; Takai, S.; Miyazaki, M. Significance of Chymase Inhibition for Prevention of Adhesion Formation. Eur. J. Pharmacol. 2004, 484, 357-359.
103. Jin, D.; Takai, S.; Sakaguchi, M.; Okamoto, Y.; Muramatsu, M.; Miyazaki, M. An Antiarrhythmic Effect of a Chymase Inhibitor After Myocardial Infarction. J. Pharmacol. Exp. Ther. 2004, 309, 490-497.
104. Fukami, H.; Imajo, S.; Ito, A.; Kakutani, S.; Shibata, H.; Sumida, M.; Tanaka, T.; Niwata, S.; Saitoh, M.; Kiso, Y.; Miyazaki, M.; Okunishi, H.; Urata, H.; Arakawa, K. Substituted 3-Phenylsulfonylquinazoline-2,4-Dione Derivatives As Novel Nonpeptide Inhibitors of Human Heart Chymase. Drug Des. Discov. 2000, 17, 69-84.
105. Watanabe, N.; Tomimori, Y.; Saito, K.; Miura, K.; Wada, A.; Tsudzuki, M.; Fukuda, Y. Chymase Inhibitor Improves Dermatitis in NC/Nga Mice. Int. Arch. Allergy Immunol. 2002, 128, 229-234.
106. Watanabe, N.; Miura, K.; Fukuda, Y. Chymase Inhibitor Ameliorates Eosinophilia in Mice Infected With Nippostrongylus brasiliensis. Int. Arch. Allergy Immunol. 2002, 128, 235-239.
107. Shiota, N.; Kakizoe, E.; Shimoura, K.; Tanaka, T.; Okunishi, H. Effect of Mast Cell Chymase Inhibitor on the Development of Scleroderma in Tight-Skin Mice. Br. J. Pharmacol. 2005, 145, 424-431.
108. Matsumoto, T.; Wada, A.; Tsutamoto, T.; Ohnishi, M.; Isono, T.; Kinoshita, M. Chymase Inhibition Prevents Cardiac Fibrosis and Improves Diastolic Dysfunction in the Progression of Heart Failure. Circulation 2003, 107, 2555-2558.
109. Doggrell, S. A.; Wanstall, J. C. Vascular Chymase: Pathophysiological Role and Therapeutic Potential of Inhibition. Cardiovasc. Res. 2004, 61, 653-662.
110. Doggrell, S. A.; Wanstall, J. C. Cardiac Chymase: Pathophysiological Role and Therapeutic Potential of Chymase Inhibitors. Can. J. Physiol. Pharmacol. 2005, 83, 123-130.
111. Hoshino, F.; Urata, H.; Inoue, Y.; Saito, Y.; Yahiro, E.; Ideishi, M.; Arakawa, K.; Saku, K. Chymase Inhibitor Improves Survival in Hamsters With Myocardial Infarction. J. Cardiovasc. Pharmacol. 2003, 41 (Suppl 1), S11-S18.
112. Takai, S.; Jin, D.; Nishimoto, M.; Yuda, A.; Sakaguchi, M.; Kamoshita, K.; Ishida, K.; Sukenaga, Y.; Sasaki, S.; Miyazaki, M. Oral Administration of a Specific Chymase Inhibitor, NK3201, Inhibits Vascular Proliferation in Grafted Vein. Life Sci. 2001, 69, 1725-1732.
113. Mucke, H. A. The Failing Heart As a Drug Target: Are We Finally Seeing Progress? Curr. Opin. Investig. Drugs 2005, 6, 870-873.
114. de Garavilla, L.; Greco, M. N.; Sukumar, N.; Chen, Z.-W.; Pineda, A. O.; Mathews, F. S.; Di Cera E.; Giardino, E. C.; Wells, G. I.; Haertlein, B. J.; Kauffman, J. A.; Corcoran, T. W.; Derian, C. K.; Eckardt, A. J.; Damiano, B. P.; Andrade-Gordon, P.; Maryanoff, B. E. A Novel, Potent Dual Inhibitor of the Leukocyte Proteases Cathepsin G and Chymase: Molecular Mechanisms and Anti-Inflammatory Activity in vivo. J. Biol. Chem. 2005, 280, 18001-18007.
115. Lee, W. L. and Downey, G. P. Leukocyte Elastase: Physiological Functions and Role in Acute Lung Injury. Am. J. Respir. Crit. Care Med. 2001, 164, 896-904.
116. Liu, H.; Lazarus, S. C.; Caughey, G. H.; Fahy, J. V. Neutrophil Elastase and Elastase-Rich Cystic Fibrosis Sputum Degranulate Human Eosinophils in Vitro. Am. J. Physiol. 1999, 276, L28-L34.
117. Voynow, J. A.; Fischer, B. M.; Malarkey, D. E.; Burch, L. H.; Wong, T.; Longphre, M.; Ho, S. B.; Foster, W. M. Neutrophil Elastase Induces Mucus Cell Metaplasia in Mouse Lung. Am. J. Physiol. 2004, 287, L1293-L1302.
118. Park, J. A.; He, F.; Martin, L. D.; Li, Y.; Chorley, B. N.; Adler, K. B. Human Neutrophil Elastase Induces Hypersecretion of Mucin , From Well-Differentiated Human Bronchial Epithelial Cells in vitro Via a Protein Kinase Cδ-Mediated Mechanism. Am. J. Pathol. 2005, 167, 651-661.
119. Suzuki, T.; Moraes, T. J.; Vachon, E.; Ginzberg, H. H.; Huang, T.-T.; Matthay, M. A.; Hollenberg, M. D.; Marshall, J.; McCulloch, C. A. G.; Abreu, M. T. H.; Chow, C.-W.; Downey, G. P. Proteinase-Activated Receptor-1 Mediates Elastase-Induced Apoptosis of Human Lung Epithelial Cells. Am. J Respir. Cell Mol. Biol. 2005, 33, 231-247.
120. Chen, H. C.; Lin, H. C.; Liu, C. Y.; Wang, C. H.; Hwang, T.; Huang, T. T.; Lin, C. H.; Kuo, H. P. Neutrophil Elastase Induces IL-8 Synthesis by Lung Epithelial Cells Via the Mitogen-Activated Protein Kinage Pathway. J. Biomed Sci. 2004, 11, 49-58.
121. Huang, C.-D.; Chen, H.-H.; Wang, C.-H.; Chou, C.-L.; Lin, S.-M.; Lin, H.-C.; Koo, H-P. Human Neutrophil-Derived Elastase Induces Airway Smooth Muscle Cell Proliferation. Life Sci. 2004 74, 2479-2492.
122. Ohbayashi,H. The Pathophysiological Contributions of Neutrophils and Neutrophil Elastase to Asthma. In Focus on Asthma Research; Tersa, M.; Ed.; Nova Medical Books: New York, 2004; pp. 67-125.
123. Sur, S.; Crotty, T. B.; Kephart, G. M.; Hyma, B. A.; Colby, T. V.; Reed, C. E.; Hunt, L. W.; Gleich, G. J. Sudden-Onset Fatal Asthma. A Distinct Entity With Few Eosinophils and Relatively More Neutrophils in the Airway Submucosa? Am. Rev. Respir. Dis. 1993, 148, 713-719.
124. Jatakanon, A.; Uasuf, C.; Maziak, W.; Lim, S.; Chung, K. F.; Barnes, P. J. Neutrophilic Inflammation in Severe Persistent Asthma. Am. J. Respir. Crit. Care Med. 1999, 160, 1532-1539,
125. Ordoñez, C. L.; Shaughnessy, T. E.; Matthay, M. A.; Fahy, J. V. Increased Neutrophil Numbers and IL-8 Levels in Airway Secretions in Acute Severe Asthma: Clinical and Biologic Significance. Am. J. Respir. Crit. Care Med. 2000, 161, 1185-1190.
126. Tremblay, G. M.; Janelle, M. F.; Bourbonnais, Y. Anti-Inflammatory Activity of Neutrophil Elastase Inhibitors. Curr. Opin. Investig. Drugs 2003, 4, 556-565.
127. Chughtai, B.; O'Riordan, T. G. Potential Role of Inhibitors of Neutrophil Elastase in Treating Diseases of the Airway. J Aerosol Med. 2004, 17, 289-298.
128. Moraes, T. J.; Zurawska, J. H.; Downey, G. P. Neutrophil Granule Contents in the Pathogenesis of Lung Injury. Curr. Opin. Hematol. 2006, 13, 21-27.
129. 1-Antitrypsin: Structure, Function, Physiology. In Acute Phase Proteins. Molecular Biology, Biochemistry, and Clinical Applications; Mackiewicz, A.; Kushner, I.; Baumann, H.; Eds.; CRC Press: Boca Raton, 1993; pp. 149-167.
130. Ranes, J.; Stoller, J. K. A Review of Alpha-1 Antitrypsin Deficiency. Semin. Respir. Crit. Care Med. 2005, 26, 154-166.
131. Dijkman, J. H. Antileucoprotease in the Airways and Emphysema. Monaldi Arch. C Chest Dis. 1995, 50, 383-387.
132. Wiedow, O.; Schröder, J.-M.; Gregory, H.; Young, J. A.; Christophers, E. Elafin: an Elastase-Specific Inhibitor of Human Skin. Purification, Characterization, and Complete Amino Acid Sequence. J. Biol. Chem. 1990. 265, 14791-14795.
133. Suzuki, T.; Wang, W.; Lin, J.-T.; Shirato, K.; Mitsuhashi, H.; Inoue, H. Aerosolized Human Neutrophil Elastase Induces Airway Constriction and Hyperresponsiveness With Protection by Intravenous Pretreatment With Half-Length Secretory Leukoprotease Inhibitor. Am. J. Respir. Crit. Care Med. 1999. 153, 1405-1411.
134. Fath, M. A.; Wu, X.; Hileman, R. E.; Linhardt, R. J.; Kashem, M. A.; Nelson, R. M.; Wright, C. D.; Abraham, W. M. Interaction of Secretory Leukocyte Protease Inhibitor With Heparin Inhibits Proteases Involved in Asthma. J. Biol. Chem. 1998, 273, 13563-13569.
135. Wright, C. D.; Havill, A. M.; Middleton, S. C.; Kashem, M. A.; Lee, P. A.; Dripps, D. J.; O'Riordan, T. G.; Bevilacqua, M. P.; Abraham, W. M. Secretory Leukocyte Protease Inhibitor Prevents Allergen-Induced Pulmonary Responses in Animal Models of Asthma. J. Pharmacol. Exp. Ther. 1999. 289, 1007-1014.
136. Forteza, R. M.; Ahmed, A.; Lee, T.; Abraham, W. M. Secretory Leukocyte Protease Inhibitor, but Not Alpha-1 Protease Inhibitor, Blocks Tryptase-Induced Bronchoconstriction. Pulm. Pharmacol. Ther. 2001, 14, 107-110.
137. Grimbert D.; Vecellio, L.; Delépine, P.; Attucci, S.; Boissinot, E.; Poncin, A.; Gauthier, F.; Valat, C.; Saudubray, F.; Antordoz, P.; Diot, P. Characteristics of EPI-hNE4 Aerosol: a New Elastase Inhibitor for Treatment of Cystic Fibrosis. J. Aerosol Med. 2003, 16, 121-129.
138. Delacourt, C.; Herigault, S.; Delclaux, C.; Poncin, A.; Levame, M.; Harf, A.; Saudubray, F.; Lafuma, C. Protection Against Acute Lung Injury by Intravenous or Intratracheal Pretreatment With EPI-HNE-4, a New Potent Neutrophil Elastase Inhibitor. Am. J. Respir. Cell Mol. Biol. 2002, 26, 290-297.
139. Honoré, S.; Attalah, H. L.; Azoulay, E.; Soussy, C.-J.; Saudubray, F.; Harf, A.; Brochard, L.; Delclaux, C. Beneficial Effect of an Inhibitor of Leukocyte Elastase (EPI-HNE-4) in Presence of Repeated Lung Injuries. Shock 2004, 22, 131-136.
140. Fujimoto, K.; Kubo, K.; Shinozaki, S.; Okada, K.; Matsuzawa, Y.; Kobayashi, T.; Sugane, K. Neutrophil Elastase Inhibitor Reduces Asthmatic Responses in Allergic Sheep. Respir. Physiol. 1995, 100, 91-100.
141. Owen, C. A.; Campbell, E. J. The Cell Biólogy of Leukocyte-Mediated Proteolysis. J. Leukoc. Biol. 1999, 65, 137-150.
142. Bank, U.; Ansorge, S. More Than Destructive: Neutrophil-Derived Serine Proteases in Cytokine Bioactivity Control. J. Leukoc. Biol. 2001, 69, 197-206
143. Uehara, A.; Muramoto, K.; Takada, H.; Sugawara, S. Neutrophil Serine Proteinases Activate Human Nonepithelial Cells to Produce Inflammatory Cytokines Through Protease-Activated Receptor 2. J. Immunol. 2003, 170, 5690-5696.
144. Mz̧yk-Kopeć, R.; Bzowska, M.; Bzowska, M.; Mickowska, B.; Mak, P.; Potempa, J.; Berets, J. Effects of Elastase and Cathepsin G on the Levels of Membrane and Soluble TNFα. Biol. Chem. 2005, 386, 801-811.
145. Wiedow, O.; Meyer-Hoffert, U. Neutrophil Serine Proteases: Potential Key Regulators of Cell Signalling During Inflammation. J Intern. Med. 2005, 257, 319-328.
146. Coyle, A. J.; Uchida, D.; Ackerman, S. J.; Mitzner, W.; Irvin, C. G. Role of Cationic Proteins in the Airway. Hyperresponsiveness Due to Airway Inflammation. Am. J. Respir. Crit. Care Med. 1994, 150, S63-S71.
147. Stefansson, S.; Yepes, M.; Gorlatova, N.; Day, D. E.; Moore, E. G.; Zabaleta, A.; McMahon, G. A.; Lawrence, D. A. Mutants of Plasminogen Activator Inhibitor-1 Designed to Inhibit Neutrophil Elastase and Cathepsin G Are More Effective in Vivo Than Their Endogenous Inhibitors. J. Biol. Chem. 2004, 279, 29981-29987.
148. Chokki, M.; Yamamura, S.; Eguchi, H.; Masegi, T.; Horiuchi, H.; Tanabe, H.; Kamimura, T.; Yasuoka, S. Human Airway Trypsin-Like Protease Increases Mucin Gene Expression in Airway Epithelial Cells. Am. J. Respir. Cell Mol. Biol. 2004, 30, 470-478.
149. Iwakiri K.; Ghazizadeh, M.; Jin, E.; Fujiwara, M.; Takemura, T.; Takezaki, S.; Kawana, S.; Yasuoka, S.; Kawanami, O. Human Airway Trypsin-Like Protease Induces PAR-2-Mediated IL-8 Release in Psoriasis Vulgaris. J. Invest. Dermatol. 2004, 122, 937-944.
150. Matsushima, R.; Takahashi, A.; Nakaya, Y.; Maezawa, H.; Miki, M.; Nakamura, Y.; Ohgushi, F.; Yasuoka, S. Human Airway Trypsin-Like Protease Stimulates Human Bronchial Fibroblast Proliferation in a Protease-Activated Receptor-2-Dependent Pathway. Am. J. Physiol. 2006, 290, L385-L395.
151. Tremblay, G. M.; Wolbink, A. M.; Cormier, Y.; Hack, C. E. Granzyme Activity in the Inflamed Lung Is Not Controlled by Endogenous Serine Protemase Inhibitors. J. Immunol. 2000, 165, 3966-3969.
152. Ronday, H. K.; van der Laan, W. H.; Tak, P. P.; de Roos, J. A. D. M.; Bank, R. A.; TeKoppele, J. M.; Froelich, C. J.; Hack, C. E.; Hogendoorn, P. C. W.; Breadveld, F. C.; Verheijen, J. H. Human Granzyme B Mediates Cartilage Proteoglycan Degradation and Is Expressed at the Invasive Front of the Synovium in Rheumatoid Arthritis. Rheumatology (Oxford) 2001, 40, 55-61.
153. Netzel-Amett, S.; Hooper, J. D.; Szabo, R.; Madison, E. L.; Quigley, J. P.; Bugge, T. H.; Antalis, T. M. Membrane Anchored Serine Proteases: A Rapidly Expanding Group of Cell Surface Proteolytic Enzymes With Potential Roles in Cancer. Cancer Metastasis Rev. 2003, 22, 237-258.
154. Wong, G. W.; Stevens, R. L. Identification of a Subgroup of Glycosylphosphatidylinositol-Anchored Tryptases. Biochem. Biophys, Res. Commun. 2005, 336, 579-584.
155. David, A.; Fridlich, R.; Aviram, I. The Presence of Membrane Proteinase 3 in Neutrophil Lipid Rafts and Its Colocalization With FcyRIIIb and Cytochrome B558. Exp. Cell Res. 2005, 308, 156-165.
156. Busse, W.; Banks-Schlegel, S.; Noel, P.; Ortega, H.; Taggart, V.; Elias, J. Future Research Directions in Asthma: An NHLBI Working Group Report. Am. J. Respir. Crit. Care Mod. 2004, 170, 683-690.